首页|复方丹参滴丸联合单硝酸异山梨酯治疗冠心病心绞痛meta分析

复方丹参滴丸联合单硝酸异山梨酯治疗冠心病心绞痛meta分析

扫码查看
目的 分析复方丹参滴丸联合单硝酸异山梨酯治疗冠心病心绞痛有效性及安全性。方法 计算机检索中国知网、维普、万方、PubMed、Web of Science数据库,检索时限为自建库起至2023年2月28日,搜集相关临床随机对照试验(RCT),根据纳排标准选择RCT,使用Review Manager 5。3软件进行meta分析。结果 纳入14项RCT,meta分析结果显示,观察组的总有效率[OR=5。01,95%CI(3。39,7。42),P<0。000 01]、心绞痛发作次数[MD=-1。75,95%CI(-2。43,-1。07),P<0。000 01]、心绞痛发作持续时间[MD=-1。87,95%CI(-2。47,-1。26)、P<0。000 01]、总胆固醇[MD=-0。96,95%CI(-1。19,-0。73),P<0。000 01]、三酰甘油[MD=-0。52,95%CI(-0。65,-0。40),P<0。000 01]、不良反应[OR=0。64,95%CI(0。43,0。97),P=0。03]均优于对照组。结论 复方丹参滴丸联合单硝酸异山梨酯+常规西药治疗冠心病心绞痛临床疗效显著,安全性高,但需更多设计严谨的多样本、多中心、双盲RCT提供证据支持。
Meta-analysis of compound Danshen Dropping Pills combined with isosorbide mononitrate in the treatment of coronary heart disease and angina pectoris
Objective To evaluate the efficacy and safety of the compound Danshen Dripping Pills combined with isosorbide mononitrate in the treatment of coronary heart disease and angina pectoris.Methods Computer retrieval was conducted on databases such as China National Knowledge Infrastructure(CNKI),VIP,Wanfang,PubMed,and Web of Science.The retrieval duration was from the establishment of the database to February 28,2023.Relevant clinical randomized controlled trial(RCT)were collected,and RCT were selected based on inclusion and exclusion criteria.meta-analysis was conducted using Review Manager 5.3 software.Results 14 RCTs were included,and the meta-analysis results showed the total effective rate(OR=5.01,95%CI[3.39,7.42],P<0.000 01),the number of angina pectoris attacks(MD=-1.75,95%CI[-2.43,-1.07],P<0.000 01),the duration of angina pectoris attacks(MD=-1.87,95%CI[-2.47,-1.26],P<0.000 01),total cholesterol(MD=-0.96,95%CI[-1.19,-0.73],P<0.000 01),triglycerides(MD=-0.52,95%CI[-0.65,-0.40],P<0.000 01),and adverse reactions(OR=0.64,95%CI[0.43,0.97],P=0.03)of the observation group were better than the control group.Conclusion The combination of compound Danshen Dripping Pills with isosorbide mononitrate and conventional Western medicine has significant clinical efficacy and high safety in the treatment of coronary heart disease and angina pectoris.However,more well-designed,multi-sample,multi-center,and double-blind RCT are needed to provide evidence support.

Compound Danshen Dripping PillsIsosorbide mononitrateCoronary heart diseaseAngina pectorisMeta-analysis

张丽萍、程青霞、郭蕾、路凡、孟诗琪、袁工植

展开 >

贵州中医药大学 贵州中医药大学第一附属医院老年病科,贵州贵阳 550005

复方丹参滴丸 单硝酸异山梨酯 冠心病 心绞痛 meta分析

2024

中国医药科学
海峡两岸医药卫生交流协会 二十一世纪联合创新(北京)医药科学研究院

中国医药科学

影响因子:1.083
ISSN:2095-0616
年,卷(期):2024.14(8)
  • 27